ATE439381T1 - Reinigung von polyreaktiven autoantikörpern und deren verwendungen - Google Patents

Reinigung von polyreaktiven autoantikörpern und deren verwendungen

Info

Publication number
ATE439381T1
ATE439381T1 AT03292060T AT03292060T ATE439381T1 AT E439381 T1 ATE439381 T1 AT E439381T1 AT 03292060 T AT03292060 T AT 03292060T AT 03292060 T AT03292060 T AT 03292060T AT E439381 T1 ATE439381 T1 AT E439381T1
Authority
AT
Austria
Prior art keywords
autoantibodies
purification
ivig
polyreactive autoantibodies
polyreactive
Prior art date
Application number
AT03292060T
Other languages
English (en)
Inventor
Real Lemieux
Josee Lamoureux
Original Assignee
Hema Quebec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31495996&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE439381(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hema Quebec filed Critical Hema Quebec
Application granted granted Critical
Publication of ATE439381T1 publication Critical patent/ATE439381T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polyethers (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
AT03292060T 2002-08-20 2003-08-20 Reinigung von polyreaktiven autoantikörpern und deren verwendungen ATE439381T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40441602P 2002-08-20 2002-08-20

Publications (1)

Publication Number Publication Date
ATE439381T1 true ATE439381T1 (de) 2009-08-15

Family

ID=31495996

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03292060T ATE439381T1 (de) 2002-08-20 2003-08-20 Reinigung von polyreaktiven autoantikörpern und deren verwendungen

Country Status (4)

Country Link
US (1) US20040101909A1 (de)
EP (1) EP1394183B1 (de)
AT (1) ATE439381T1 (de)
DE (1) DE60328747D1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004248155B2 (en) 2003-06-09 2008-10-23 Redox-Reactive Reagents L.L.C. Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
EP1652859A1 (de) * 2004-11-02 2006-05-03 ZLB Behring AG Immunoglobulinfraktionen
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives
WO2022104147A1 (en) 2020-11-13 2022-05-19 Beckman Coulter, Inc. Additives for reducing non-specific interactions between fluorescent polymer conjugates and cells in a biological sample
EP2233499A1 (de) * 2009-03-26 2010-09-29 CSL Behring AG Antikörperzusammensetzung mit veränderter Fab-Sialylierung
EP2258727A1 (de) * 2009-05-27 2010-12-08 Wezen Biopharmaceuticals S.r.l. A Socio Unico Immunglobulinzubereitung zur Behandlung einer Autoimmunerkrankung und Immunsystemstörungen
US20100330102A1 (en) * 2009-06-26 2010-12-30 Wezen Biopharmaceuticals Srl A Socio Unico Immunoglobulin preparation for the treatment of hiv-1 infection
EP2482074A1 (de) * 2011-01-27 2012-08-01 Medizinische Hochschule Hannover Verfahren und Mittel zur Diagnose von Vaskulitis
WO2013098420A1 (en) 2011-12-28 2013-07-04 Immunoqure Ag Method of isolating human antibodies
SI2961426T1 (sl) 2013-02-26 2020-01-31 Baxalta GmbH Zdravljanje motenj centralnega živčnega sistema z intranazalnim dajanjem imunoglobulina G
AU2017250778B2 (en) 2016-04-15 2021-09-23 Beckman Coulter, Inc. Photoactive macromolecules and uses thereof
CN109843327B (zh) 2016-07-07 2022-05-13 小利兰·斯坦福大学托管委员会 抗体佐剂缀合物
AU2017376460A1 (en) 2016-12-13 2019-06-20 Bolt Biotherapeutics, Inc. Antibody adjuvant conjugates
WO2018191746A1 (en) 2017-04-14 2018-10-18 Bolt Biotherapeutics, Inc. Immunoconjugate synthesis method
CA3100544A1 (en) 2018-05-17 2019-11-21 Bolt Biotherapeutics, Inc. Immunoconjugates
CA3110510A1 (en) 2018-08-29 2020-03-05 Bolt Biotherapeutics, Inc. Immunoconjugates targeting egfr
US11584825B2 (en) 2018-12-14 2023-02-21 Beckman Coulter, Inc. Polymer dye modification and applications
CA3151662A1 (en) 2019-09-04 2021-03-11 Bolt Biotherapeutics, Inc. Immunoconjugate synthesis method
AU2022216619A1 (en) 2021-02-05 2023-09-07 Beckman Coulter, Inc. Compositions and methods for preventing non-specific interactions between polymer dyes-antibody conjugates
US20240400893A1 (en) 2021-09-30 2024-12-05 Beckman Coulter, Inc. Water-soluble tetrahydropyrene based fluorescent polymers
US20250383357A1 (en) 2022-07-01 2025-12-18 Beckman Coulter, Inc. Novel fluorescent dyes and polymers from dihydrophenanthrene derivatives
WO2024044327A1 (en) 2022-08-26 2024-02-29 Beckman Coulter, Inc. Dhnt monomers and polymer dyes with modified photophysical properties
EP4680677A1 (de) 2023-03-17 2026-01-21 Beckman Coulter, Inc. Benzothienpyrrolcyaninfarbstoffe
CN121866309A (zh) 2023-09-21 2026-04-14 贝克曼库尔特有限公司 用于流式细胞术的二氢菲（dhp）桥接染料

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55124719A (en) * 1979-03-22 1980-09-26 Kowa Co Preparation of immune globulin administrable by intravenous injection
DE19505266C1 (de) * 1995-02-16 1996-10-02 Brahms Diagnostica Gmbh Verwendung von polyklonalen humanen anti-hTg-Autoantikörpern als Reagenz für die klinische Diagnostik von Schilddrüsen-Autoimmunerkrankungen sowie Reagenziensatz für eine Bestimmung von anti-hTg-Autoantikörpern in Patientenseren
DE19900503A1 (de) * 1999-01-08 2000-07-13 Apotech Res & Dev Ltd Verwendung einer Zusammensetzung zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen mit erhöhten extrazellulären FasL-Titern, Verfahren zur prophylaktischen Eignungs- bzw. Qualitätskontrolle derselben, Verfahren zur Herstellung von Arzneimitteln zur Behandlung obiger Krankheiten mit gesteigerter Wirksamkeit
FR2794461B1 (fr) * 1999-06-07 2004-01-23 Lab Francais Du Fractionnement Procede de preparation de nouvelles fractions d'ig humaines possedant une activite immunomodulatrice

Also Published As

Publication number Publication date
EP1394183A1 (de) 2004-03-03
US20040101909A1 (en) 2004-05-27
EP1394183B1 (de) 2009-08-12
DE60328747D1 (de) 2009-09-24

Similar Documents

Publication Publication Date Title
ATE439381T1 (de) Reinigung von polyreaktiven autoantikörpern und deren verwendungen
DE602004029252D1 (de) Aglycosyl-anti-cd154 (cd40-ligand) antikörper und deren verwendungen
ATE354655T1 (de) Humane antikörper gegen ctla-4 und deren verwendungen
PL374178A1 (en) Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
ATE470676T1 (de) Anti-vegf-2 antikörper
LU91271I2 (fr) Natalizumab et ses dérivés pharmaceutiquement acceptables (TYSABRI)
BR0307788A (pt) método de redução e tratamento de imunossupressão induzida por uv-b
ES2148332T3 (es) Procedimiento para la produccion de concentrado de inmunoglobulinas g.
DE60236528D1 (de) Schwach gefärbte natriumarme benzoxazinon-uv-absorber und verfahren zu ihrer herstellung
WO2004063351A3 (en) IDENTIFICATION AND ENGINEERING OF ANTIBODIES WITH VARIANT Fc REGIONS AND METHODS OF USING SAME
ATE451349T1 (de) Neue verbindungen als entzündungshemmende, immunmodulierende und antiproliferative mittel
BR0315157A (pt) Métodos de tratar doença de alzheimer empregando-se anticorpos direcionados contra peptìdeo beta amilóide e composições deste
ATE517920T1 (de) Humanisierte antikörper gegen interferon-alpha- rezeptor-1 (ifnar-1)
CY1112229T1 (el) Αντισωματα κατευθυνομενα εναντι οξειδωμενης απολιποπρωτεϊνης β
NO20050091L (no) Fremgangsmater for fremstilling av fibrinogen
ATE557040T1 (de) Rekombinante antikörper sowie zusammensetzungen und verfahren zu deren herstellung und verwendung
DE69333484D1 (de) Umgestaltete monoklonale Antikörper gegen ein Immunglobulinisotyp
ATE393170T1 (de) Humanisierter antikörper gegen fibroblastenwachstumsfaktor 8 und fragment des antikörpers
ATE401912T1 (de) Methoden der zubereitung von immunglobulin und dessen verwendungen
BR0112123A (pt) Composto
DE69010897D1 (de) Verwendung von monoklonalen Antikörpern gegen B2-Mikroglobulin.
ATE303390T1 (de) Sulfat von cephemverbindung
DE60229845D1 (de) Moraxella (branhamella) catarrhalis antigene
BR9611520A (pt) Composto hemo-reguladores.
ATE421586T1 (de) Moraxella (branhamella) catarrhalis antigene

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1394183

Country of ref document: EP